Quantcast Nanostart Majority-Owned Magforce Announces Successful Completion Of Final Clinical - Congoo
 
 
IP AND PATENTS Log In
Nanostart Majority-Owned MagForce Announces Successful Completion of Final Clinical
Have an interest in this Story?
Sign Up for Real-Time email updates
NewsBlaze  | November 03, 2009

According to a previous study among a large patient population, the median survival time following diagnosis of a glioblastoma recurrence and treatment with conventional therapy (surgery, chemotherapy and radiation) is 6.2 months. The primary objective for the Nano-Cancer therapy study was to demons...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Matthew Clark Matthew Clark
Mentor
Entrepreneur
Alexandr Migunov Alexandr Migunov
Head of the Project
Real Estate Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.